Verily

GLP-1s can be transformative for weight loss, but only with the right support. Our team at Verily will be hosting a webinar on April 30th about how Verily Lightpath is uniquely positioned to deliver data-driven, comprehensive clinical care that can help optimize outcomes and costs related to GLP-1 medications. This is going to be a great discussion with Verily experts David Burdick and Sarah Thompson, Heidi Guetzkow of Aon, and moderator Lydia Ramsey Pflanzer of Endpoints News. If you’re interested in hearing more about unlocking the potential of GLP-1s, register here: https://lnkd.in/gwXRYRCt

💓 Traditionally, resting heart rate (RHR) is determined through clinical measurements during physical exams or electrocardiography (ECG). New research published in JMIR Publications found that RHR can be measured easily and accurately using a wearable device, specifically the Verily Study Watch, within a large, heterogeneous cohort. Participants of the study were part of the Project Baseline Health Study, a collaboration with Verily, Duke Clinical and Translational Science Institute and Stanford University School of Medicine. Read the results: https://lnkd.in/dcNnSrkq #wearables #ClinicalResearch

GLP-1 accessibility and achieving lasting, meaningful clinical outcomes are major challenges for the healthcare ecosystem. In a new blog, Dr. Vindell Washington breaks down how the clinical implications are considered in the design of Verily Lightpath* — our personalized, AI-powered chronic-care solution — to directly address these challenges. https://veri.ly/42ewStQ If you want to dive deeper into how Verily Lightpath can support payer and employer populations with GLP-1 management, register for our webinar on April 30: https://veri.ly/4hUGrUD #PrecisionHealth #AIInHealthcare #DiabetesManagement *To be available in 2026

Exciting to see Verily Sightline, our public health monitoring solution, featured on NBC Bay Area!  Data from San Francisco and San Jose wastewater plants reveal that Influenza A is declining, but Influenza B has spiked, highlighting the power of real-time public health insights. According to Verily’s Amy Lockwood, the innovation allows us to track pathogens efficiently, moving beyond traditional methods that rely on individual doctor visits. https://lnkd.in/ddputiGG If you have Spring Break travel plans, be sure to check out our wastewater tracker before you head to your destination! https://veri.ly/42pvrtV #wastewater #PublicHealth #InfluenzaA #InfluenzaB

Imagine #AI as a personalized guide for each patient, offering support, anticipating needs, and adjusting in real time. While healthcare engagement is a common topic, digital tools often fall short. AI and personalized data offer great potential, yet many organizations face low adoption. At ViVE last month in Nashville, Erich S. Huang, MD, PhD of Verily discusses the future of AI in healthcare, including patient engagement, automation versus human interaction, and Verily's Lightpath platform for chronic care management. https://lnkd.in/gZ5bruwg #AI #precisionhealth #patientengagement #chronicdiseasemanagement #diabetes #CVD #obesity #healthtech #digitalhealth

We invite you to meet Verily experts at one of our upcoming events to hear how we’re making healthcare more personal and precise. 📍 Boston, MA - Bio-IT World Conference, April 2-4 📍 New York, NY - The Conference Board Employee Health Care Conference, April 8-9  📍 Nashville, TN - Business Group on Health 2025 Annual Conference, April 22-24  📍 New Orleans, LA - ACRP - Association of Clinical Research Professionals 2025, April 24-27  📍 Anaheim, CA - NACCHO 2025 Preparedness Summit, April 29 - May 2 Subscribe to our newsletter to know where to find us next and the latest Verily news: https://veri.ly/3XBc9PG #PrecisionHealth #HealthTech #HealthInnovation

Our partnership with Bangor University is an exciting advancement in Verily’s mission to establish an international pathogen monitoring network as we expand our capabilities to Europe. Thank you for highlighting our collaboration, Davey Jones!

Our chronic care app includes access to a team of dedicated health coaches who help members with diabetes thrive. Marti Fernandes, BS, EP is one of them. Get to know why she’s so passionate about what she does. https://veri.ly/4iFEUDm #DiabetesAlertDay #DiabetesCare #DiabetesManagement

Recent findings from BCBS suggested that up to 30% of patients who start on GLP-1 drugs discontinue use before meaningful weight loss can be achieved. Research also suggests that when taking GLP-1s, patients need to make changes to their diet and exercise to maximize the clinical benefits. I’m excited that Verily Lightpath, which will be available in 2026, will address this challenge. Through the app, participants can interact with registered dietitians, coaches, and clinicians through our affiliated medical group, who work together to provide personalized, ongoing support to drive sustained behavior change. Find out more in the blog by Dr Vindell Washington our Chief Clinical Officer at https://lnkd.in/g4gZFsw7

Discover a better way to manage clinical trial protocols. Digital protocols—powered by Verily’s proprietary, AI-driven technology—enable more seamless and cost-effective clinical trial operations. Learn more in the blog, The Role of AI in Powering Digital Protocols: https://veri.ly/4iX2vyT #ClinicalTrials #CTMS #AIInHealthcare